Sitka Secures $ 14 Million Series A Funding Led by Venrock to Help Transform Specialty Care
SAN FRANCISCO, February 9, 2021 / PRNewswire / – Sitka, a customizable video software platform and network of specialist virtual providers, announced today that it has lifted $ 14 million in a Series A financing led by Venrock, with participation from existing investors Optum Ventures, Homebrew, First Round Capital and Lifeforce Capital. Sitka will use the new funding to accelerate product development, expand growth with new and existing partners, and recruit new talent in business development, product and engineering.
Sitka’s telehealth platform and specialist network have become essential tools within the healthcare industry by providing trusted specialist recommendations through vConsults, Sitka’s peer-to-peer asynchronous video consultations. Over the past year, Sitka has forged national healthcare partnerships with major healthcare systems and primary care providers, including ChenMed, a primary care group and the Medicare Advantage plan, to help transform specialist care and their use.
“We launched Sitka to separate the economic incentives for specialist service providers to provide paid care and to integrate specialist care into a value-based care system that works best for primary care providers, specialists and, most importantly, for patients, ”said Kelsey Mellard, CEO of Sitka. “This year, the pandemic has accelerated the adoption of digital healthcare delivery and we are excited to partner with healthcare plans, provider groups and healthcare leaders to make significant improvements in delivery. health care and the management of Part B expenditure. ”
“To keep patients healthy, happy and at home, we are leveraging technology to find meaningful ways to deliver high-quality, personalized primary care,” shares Gordon chen, MD, Chief Medical Officer of ChenMed. “Sitka’s platform allows us to continue to extend our model of high-quality patient care in a safe and efficient manner, while improving the doctor-patient relationship and reducing unnecessary costs for patients. Sitka’s platform has been an essential tool for our clinicians and patients to access significant specialist expertise throughout this difficult time, and we look forward to further expanding its use after COVID-19. “
As part of its commitment to improving the specialty care experience for patients and providers, Darshak sanghavi, MD joined Sitka as an advisor. As a leading physician and public health spokesperson, Sanghavi will help advance Sitka’s mission to increase access to quality, reliable care.
“I am honored to join Sitka as an advisor,” Sanghavi said. “Amid the current public health crisis and beyond, expanding equitable access to specialist care for communities across the country is critical. Sitka is a key tool in providing fast, high-quality care no matter where the patient is.
Sitka’s service enables organizations and healthcare providers to quickly adapt to the changing healthcare landscape, while addressing healthcare inequalities and enabling hundreds of do the work of thousands by connecting patients to clinicians in a fast-paced HIPAA-compliant environment.
“We are delighted to partner with such a talented and knowledgeable team and the addition of Dr Sanghavi further strengthens our enthusiasm,” said Bob kocher, MD, partner at Venrock. “While the pandemic has fundamentally changed our nation’s healthcare system, we are seeing the role of telehealth in expanding access to specialist providers in communities across the United States, Sitka is poised to become the main provider of specialist care. ”
Sitka is a customizable telehealth platform supercharged by a network of specialist remote providers. By improving the skills of primary care providers, reducing the cycle of care and enabling patient inclusion, Sitka is transforming specialty care in the United States. Founded by healthcare experts in medicine, technology, policy and product, Sitka’s mission is to foster informed, efficient and reliable care for all patients by every provider. Sitka investors include Venrock, Optum Ventures, First Round, Rock Health, Homebrew, Lifeforce Capital and Box Group.
Originally established as a venture capital arm of the Rockefeller family in 1969, Venrock partners with entrepreneurs to create some of the most disruptive and successful businesses in the world. With a primary focus on tech and health, portfolio companies have included Apple, Intel, Gilead, Checkpoint, Doubleclick, Illumina, Millennium, Nest, CloudFlare, 10x, and Dataminr.